Related Experiment Videos
Adrenergic sulfonanilides. 4. Centrally active beta-adrenergic agonists
Journal of Medicinal Chemistry
|May 1, 1976
Summary
Researchers explored soterenol analogs for central nervous system (CNS) effects. Certain modifications yielded potent morphine antagonists and appetite suppressants, but structural changes impacted activity and toxicity.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Neuroscience
Background:
- Soterenol analogs were synthesized and evaluated for biological activity.
- Previous research indicated potential central nervous system (CNS) effects of related compounds.
Purpose of the Study:
- To investigate the central nervous system (CNS) activities of novel soterenol analogs.
- To identify structural features influencing morphine antagonistic and anorexiant properties.
- To correlate CNS activity with potential toxicity.
Main Methods:
- Synthesis of a series of soterenol analogs with varied substituents.
- Pharmacological evaluation of CNS activity, including morphine antagonism and appetite suppression.
- Assessment of toxicity, focusing on alpha-adrenergic stimulation.
Main Results:
- Several soterenol analogs demonstrated potent morphine antagonistic and anorexiant properties.
- Lipophilic nitrogen substituents, such as 1,1-dimethyl-2-phenethyl and cyclopropyl groups, enhanced CNS activity.
- Minor alterations to aromatic or side-chain structures significantly diminished central activity.
- Toxicity was linked to the alpha-adrenergic stimulating effects of the compounds.
Conclusions:
- Specific lipophilic substituents on soterenol analogs are crucial for potent CNS activity, including morphine antagonism and appetite suppression.
- Structural modifications require careful consideration to maintain efficacy and minimize toxicity.
- Alpha-adrenergic activity is a key determinant of toxicity in this series of compounds.